We’re proud to announce that POF has been named Lexology’s exclusive ‘Thought Leader’ for IP in Australasia, recognizing the performance of Inspired – the POF Blog throughout Q4 of 2018! Lexology’s awards are chosen by measuring the number of reads, and the overall readership score that Lexology assigns to each article in that quarter. This …
>> Read more
We’re proud to announce that POF attorneys Dr Annabella Newton and Dr David Hvasanov have been named among this year’s Rising Stars in the IP Stars awards. This is a fantastic achievement for both Annabella and David, and we’d like to congratulate them on their win. Each year IP Stars research analysts receive and analyse a …
>> Read more
The recent Federal Court decision surrounding Trident Foods Pty Ltd sends a warning to trade mark owners to exercise actual control over licensees or risk a messy non-use battle. The decision involved two appeals, one against a refusal to remove one of Trident Foods’ (TF) mark TRIDENT from the Register for non-use. The Registrar’s Delegate …
>> Read more
Parallel imports, also called grey imports, are genuine goods imported into Australia by someone other than the trade mark owner or an authorised licensee. Grey goods are generally sold at a discounted price, or may be of a different standard or quality from goods intended by the trade mark owner for the Australian market. In …
>> Read more
Recent legislative changes have removed a reporting burden from patentees applying for pharmaceutical extensions of term. Section 76A of the Australian Patents Act (the Act) was introduced alongside the pharmaceutical extension of term scheme in order to collect data regarding each granted extension. It was intended to assist in evaluating whether pharmaceutical extensions of term …
>> Read more
The two key remedies sought by intellectual property owners in infringement cases are an injunction to stop the infringing conduct and compensation in the form of damages or an account of profits. Typically, the Court will determine the question of infringement separately and prior to considering what, if any, compensation should be awarded. In many instances …
>> Read more
In what is a quite recent but unpublicised development, IP Australia now record “special” non-English characters (i.e. accented letters, umlauts, diaeresis and the like) for applicants and inventor names on new incoming patent applications. Until recently, an inventor named, for example, Åsa or Björn in a PCT national phase entry designating Australia would be recorded …
>> Read more
Congratulations to University of Tasmania for winning both the KCA Research Commercialisation Award and People’s Choice Award at last night’s KCA Awards dinner! The University of Tasmania’s award-winning pitch revolved around a research project in rock lobster biology, and a subsequent commercial sublicense from UTAS that will see the world’s first commercial‐scale tropical rock lobster …
>> Read more
The first interlocutory injunction restraining the launch of a biosimilar pharmaceutical product was granted by the Federal Court of Australia in a decision on 12 June 2018¹. Background The decision concerns the monoclonal antibody rituximab, a biologic therapy which is prescribed in Australia to treat a number of immunology conditions including lymphoma, chronic lymphocytic leukaemia …
>> Read more
A recent opposition decision of the Australian Patent Office¹ focused on the level of disclosure which is required in a patent specification to properly enable and support the claimed invention. This decision illustrates the importance of providing an enabling disclosure across the full width of the claimed invention and, where possible, providing a principle of …
>> Read more
